Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00816101 · ClinicalTrials.gov registry record · Phase 2
Efficacy Study of a New Antimicrobial Wound Dressing to Treat Wounds Caused by Curettage and Electrodesiccation
A Phase 2 study of Acute Wounds, sponsored by Vomaris Innovations.
- Completed
- Registry status
- Phase 2
- Development phase
- 26
- Enrollment target
- 1
- Study location
NCT00816101 is a Phase 2 study of Acute Wounds that has completed, run by Vomaris Innovations. The registered enrollment target is 26 participants. The trial reports 1 study location across 1 state.
The verdict
NCT00816101, a Phase 2 study of Acute Wounds, has completed, sponsored by Vomaris Innovations.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 26 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this pilot clinical study is to compare healing rates, pain levels, and incidence of wound complications including infection with the use of a moist PROCELLERA™ Antimicrobial Wound Dressing when compared to a standard dressing, Mepilex® Border Lite, following curettage and electrodesiccation of skin lesions.
Conditions Studied
Interventions
- OTHER Procellera™ Antimicrobial Dressing
- OTHER Mepilex® Border Lite
- DEVICE Adhesive Bandage
Study Locations (1)
Arizona
- Sheftel Associates Dermatology - Tucson
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2008-03 |
| Est. Completion | 2008-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00816101
The ClinicalTrials.gov registry entry for NCT00816101 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vomaris Innovations, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Acute Wounds appearing as the primary indexed condition, and to 3 interventions - of which Procellera™ Antimicrobial Dressing is the first listed.
NCT00816101 reports 1 study location spanning 1 distinct geographic area - top geographies include Arizona.
Frequently Asked Questions
What is clinical trial NCT00816101 about?
NCT00816101 is a clinical study titled "Efficacy Study of a New Antimicrobial Wound Dressing to Treat Wounds Caused by Curettage and Electrodesiccation". The purpose of this pilot clinical study is to compare healing rates, pain levels, and incidence of wound complications including infection with the use of a moist PROCELLERA™ Antimicrobial Wound Dressing when compared to a standard dressing, Mepilex® Border Lite, following curettage and electrodesi...
What is the current status of trial NCT00816101?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 26 participants. The study started on 2008-03. Estimated completion is 2008-10.
What conditions does trial NCT00816101 study?
This clinical trial studies the following conditions: Acute Wounds.
What interventions are being tested in trial NCT00816101?
The interventions under investigation include: Procellera™ Antimicrobial Dressing (OTHER), Mepilex® Border Lite (OTHER), Adhesive Bandage (DEVICE).
Who is sponsoring clinical trial NCT00816101?
This trial is sponsored by Vomaris Innovations, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00816101 being conducted?
This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.